The nose works continuously to clear microorganisms, making it difficult for antimicrobials to reach and kill bacteria. 3M™ Skin and Nasal Antiseptic (Povidone-Iodine Solution 5% w/w [0.5% available iodine] USP) Patient Preoperative Skin Preparation is the answer. The solution consists of film-forming materials that enable the active ingredient to coat and adhere to the nares.
Designed to be used in the preoperative process, 3M™ Skin and Nasal Antiseptic replaces patient-applied nasal treatments. It’s a simple step that makes a difference in helping to reduce the risk of surgical site infections. 2-6Click here to get the clinical information.
Staphylococcus aureus is the leading cause of surgical site infections7
Most infections are caused by the patient’s own nasal flora8-10. 3M™ Skin and Nasal Antiseptic is the only product designed to work within the preoperative process to quickly and effectively reduce S. aureus colonization in the nares1, giving you the confidence that patients are entering surgery with a reduced risk of infection. It works within one hour to kill 99.2% of bacteria and lasts for at least 12 hours, providing superior protection against surgical site infections.
3M™ Skin and Nasal Antiseptic works with a one time application prior to surgery and easily fits into the preoperative process, so compliance is ensured. Try it for yourself. Click here for your free trial.
(1) 3M Study-05-011100.
(2) Phillips M., et al. Preventing Surgical Site Infections: A Randomized, Open-Label Trial of Nasal Mupirocin Ointment and Nasal Povidone-Iodine Solution. Infect Control Hosp Epidemiol 2014;35(7):826-32
(3) Brown L., et al. (2014, June) The Effects of Universal Intranasal Povidone Iodine Antisepsis on Total Joint Replacement Surgical Site Infections. Poster present at the APIC National Conference, Anaheim, CA
(4) Hogenmiller J., et al. (2011, June) Preventing Orthopedic Total Joint Replacement Surgical Site Infections through a Comprehensive Best Practice Bundle/Checklist. Poster presented at the APIC National Conference, Baltimore MD.
(5) Waibel M., (2013, June) Revisiting Process Improvement for Total Joint Arthrophlasty Surgical Site Infections. Poster presented at the APIC National Conference, Ft Lauderdale, FL.
(6) Bebko S., et al. Effect of a Preoperative Decontamination Protocol on Surgical Site Infections in Patients Undergoing Elective Orthopedic Surgery with Hardware Implantation. JAMA Surg, Published online March 04, 2015. doi:10.1001/jamasurg.2014.3480
(7) Sievert DM, et al. Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013; 34(1):1-14.
(8) Wertheim, HFL, et al. Risk and Outcome of Nosocomial Staphylococcus aureus Bacteraemia in Nasal Carriers versus Non-carriers. The Lancet 2004;364: 703-705
(9) Perl TM., et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. NEJM 2002;346(24):1871-77.
(10) Kluytmans JAJW, et al. Nasal Carriage of Staphylococcus aureus as a Major Ricsk Factor for Wound Infections after Cardiac Surgery. Journal of Infectious Diseases1995; 171:216-219.